Bristol-MyersSqu (BMY)
$59.30
0.11 (0.19%)
BMY Stock Quote Delayed 30 Minutes
Nuclear Power Is Solving the World’s Looming Energy Crisis
Decades ago, the nuclear industry seemed to be limping toward certain extinction, or at least irrelevancy. But then a funny thing happened: AI arrived on the scene and started demanding spectacular volumes of electric power that existing sources would not be able to provide.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$61.05
Market Cap
123.89B
PE Ratio
-13.43
EPS
-4.4144
Volume (Avg. Vol.)
10.63M
Day's Range
$59.18 - $61.49
52-Week Range
$38.14 - $63.33
Dividend & Yield
$2.42 (4.08%)
BMY Stock Predictions, Articles, and Bristol-MyersSqu News
3 Biotech Stocks With Promising Drug Pipelines: August 2024
The biotech stocks with promising pipelines could see shares soar if drugs in late-stage trials get FDA approval.
The 3 Biggest Earnings Beats for Q2 as of August 1, 2024
The stocks serving up the biggest earnings beats may just go on to offer investors fabulous returns going forward.
Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore
These value stocks are priced right for bargain hunters seeking deals in the market at the moment.
The Top 3 Healthcare Stocks to Buy Now: Summer 2024
Investors should consider the long term prospects of the following three healthcare stocks as the U.S. population ages.
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q2 2024
BMY stock results show that Bristol-Myers Squibb beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
3 Defensive Stocks to Shield Your Portfolio in July
Fed Chair Jerome Powell’s cautious economic outlook adds to the allure of defensive stocks offering stable long-term returns
7 Value Stocks to Buy at a 52-Week Low in July
Bottom fishers and contrarians take note: each of these seven value stocks to buy is on sale after recently hitting new 52-week lows.
3 Undervalued Stocks Ready for a Breakout This Summer
Undervalued breakout stocks are heating up this summer. Discover three hidden gems with strong fundamentals ready to outperform the market.
The 7 Best Warren Buffett Stocks to Buy in July 2024
Some investors may say value investing is dead, but its never a bad time to look at some of the best Warren Buffett stocks to buy
3 Defensive Stocks to Buy During the Market Dip
Clearway, Bristol-Myers Squibb and Universal Corp. are defensive stocks to buy on the dip, offering stable dividends and significant upside.
You’ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.
Pharmaceutical stocks can be considered risky, but when their trials get approved by FDA, the stock can go to the moon.
7 Dividend Stocks to Buy Now: June 2024
These dividend stocks to buy now will reward investors with income now and growth as the market breadth expands.
3 Warren Buffett Stocks to Buy Now: June 2024
If you have a long-term view of the market, it’s a good time to look for some Warren Buffett stocks to buy now.
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
Biotech stocks operate under a core ethos. While there’s been much talk about financially viable sectors – from tech to cryptocurrencies to even precious metals…
